Thursday, June 7, 2007

Aortic Dissection: Perspectives for the Vascular Surgeon in the TEVAR Era
Supported by an educational grant from Medtronic
BCC: Ballroom IV
Moderator: Richard P. Cambria, MD
Massachusetts General Hospital, Boston, Mass.

At the end of this session, participants should be able to:

1. Acquire complete knowledge of the classification/pathologic
   anatomy and treatment of acute aortic dissection.
2. Define role of surgical techniques in the treatment of malperfusion syndromes.
3. Understand technical considerations of TEVAR in acute dissection.
4. Interpret results to date with TEVAR for acute dissection.
   

6:30 am
Anatomy of Dissection
Richard P. Cambria, MD, Massachusetts General Hospital, Boston, Mass.

6:45 am
Surgical Management of Malperfusion Syndromes
James H. Black, MD, Johns Hopkins Hospital, Baltimore, Md.

7:00 am
TEVAR in Acute Dissection—Technical Considerations
Rodney A. White, MD, Harbor-UCLA Medical Center, Torrance, Calif.

7:15 am
Results with TEVAR for Acute/Chronic Dissection
Venkatesh G. Ramaiah, MD, Arizona Heart Institute, Phoenix, Ariz.

7:30 am
Clinical Trials of TEVAR in Dissection: Present and Future
Joseph V. Lombardi, MD,
Thomas Jefferson University Hospital, Philadelphia, Pa.

7:45 am
Panel Discussion: Questions and Answers

Carotid Angioplasty and Stenting:
How Will the Current Evidence Affect Your Practice?
Supported by an educational grant from Abbott Vascular
BCC: Rooms 309/310
Moderator: Jon S. Matsumura, MD
Northwestern Memorial Hospital, Chicago, Ill.

At the end of this session, participants should be able to:

1. Review pertinent clinical evidence of carotid artery stenting.
2. Determine appropriate therapeutic options for patients with
   carotid artery stenosis.
3. Comply with current Medicare coverage policy.

6:30 am
Summary of US IDE/PMS Registry Data
Alan B. Lumsden, MD, Methodist DeBakey Heart Center, Houston, Texas

6:45 am
Design and Lead-In Results of CREST
Robert W. Hobson, MD, UMDNJ-NJ Medical School, Newark, N.J.

7:00 am
Review of Stopped Trials: SPACE and EVA 3-S
Jean Pierre Becquemin, MD, Hospital Henri Mondor, Creteil, France

7:15 am
Design of ACT 1 Trial
Jon S. Matsumura, MD, Northwestern Memorial Hospital, Chicago, Ill.

7:30 am
Details of the 2007 CMS NCD on Carotid Stenting
Robert M. Zwolak, MD, Dartmouth-Hitchcock Medical Center, Lebanon, N.H.

7:45 am
Panel Discussion: Questions and Answers

Moderators:
K. Craig Kent, MD
New York Presbyterian Hospital, New York, N.Y.
    
Joseph R. Schneider, MD
Northwestern University Feinberg School of Medicine, Chicago, Ill.

At the end of this session, participants should be able to:

1. Discuss the methodology, results, and conclusions
   of the research presented in vascular health.
2. Gain knowledge of new technology for diagnosis
   and treatment of vascular disease.

8:35 am
S1. Reappraisal of Internal Carotid Artery Stenosis Velocity Thresholds
Utilizing High-Resolution B-Mode Ultrasound Validated With CTA:
Do Current Practice Thresholds Overestimate Carotid Bifurcation Disease?

8:51 am
S2. Increased National In-Hospital Mortality Following
Carotid Stenting as Compared to Carotid Endartrectomy

9:07 am
S3. National Endovascular and Total Vascular Clinical
Experience of Vascular Fellows and General Surgical Residents

9:23 am
Resident Research Prize Paper
Nanotechnology and Nitric Oxide: A Novel
Approach to Inhibit Neointimal Hyperplasia

Moderators:
Alan B. Lumsden, MD
Methodist DeBakey Heart Center, Houston, Texas

Anton N. Sidawy, MD  
VA Medical Center, Washington, D.C. 

At the end of this session, participants should be able to:

1. Discuss the methodology, results, and conclusions
   of the research presented in vascular health.
2. Gain knowledge of new technology for diagnosis
   and treatment of vascular disease.

1:30 pm
S4. Surgeon Experience Predicts Outcomes for Elective
Endovascular Aortic Abdominal Aneurysm Repair;
Results from the National Medicare Database

1:46 pm
S5. What Is the Clinical Utility of a Six-Month CT in the
Follow-up of Endovascular Aneurysm Repair Patients?

2:02 pm
S6. Endovascular vs. Open Surgical Repair of Ruptured Abdominal
Aortic Aneurysms in Hemodynamically Stable and Unstable Patients:
Midterm Outcomes of a Five-year Prospective Intent-to-Treat Study

2:18 pm
S7. Colonic Ischemia Following AAA Repair in the Era of EVAR

2:34 pm
S8. Mathematical Analysis of DICOM CT Datasets for
Fenestrated and Branched Endografts: Can it all be Automated?

2:50 pm
S9. Percutaneous Femoral Artery Access:
The New Gold Standard for Endovascular Aortic
Aneurysm Repair and Its Impact on Arterial Patency

3:06 pm
S10. Spinal Cord Complications After Thoracic Aortic Surgery:
Long-term Survival and Functional Status Varies with Deficit Severity

At the end of this session, participants should be able to:

1. Discuss the methodology, results, and conclusions
   of the research presented in vascular health.
2. Gain knowledge of new technology for diagnosis
   and treatment of vascular disease.

4:00 pm
S11. Stent Graft Repair (TEVAR) of Complex Thoracic
Aortic Pathology: A Multicenter, Prospective Trial

4:16 pm
S12. Balloon Angioplasty Maturation of Arteriovenous Fistulae:
A New Paradigm for Surveillance, Maintenance and Improved Function

4:32 pm
S13. Does the Type of Embolic Protection Influence
Outcome in Carotid Artery Stenting?

4:40 pm
S14. Multiple Stents in Carotid Artery Stenting Is Associated
with Increased Stroke Rates: Review of the CREST Lead-in Data

5:04 pm
S15. Neurologic Complications Associated with
Endovascular Repair of Thoracic Aortic Pathology.
Incidence and Risk Factors. A Study of the EUROSTAR Registry